The estimated Net Worth of Edgar Lee is at least $1.28 Billion dollars as of 15 December 2017. Mr. Lee owns over 6,000 units of Sorrento Therapeutics Inc stock worth over $60 and over the last 14 years he sold SRNE stock worth over $1,277,527,040. In addition, he makes $215,250 as Independent Director at Sorrento Therapeutics Inc.
Edgar has made over 11 trades of the Sorrento Therapeutics Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of SRNE stock worth $51,480 on 15 December 2017.
The largest trade he's ever made was selling 7,064,036 units of Sorrento Therapeutics Inc stock on 1 May 2013 worth over $674,615,438. On average, Edgar trades about 922,739 units every 127 days since 2011. As of 15 December 2017 he still owns at least 6,000 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Mr. Lee stock trades at the bottom of the page.
Edgar Lee serves as Independent Director of the Company. Mr. Lee is currently a Managing Director at Oaktree Capital Management. Mr. Lee founded and was the portfolio manager of Oaktree's $5.5bn Strategic Credit strategy. He was also the Chief Executive Officer and Chief Investment Officer of Oaktree's three business development companies (BDCs) including Oaktree Specialty Lending (Nasdaq: OCSL) and Oaktree Strategic Income Corporations (Nasdaq: OCSI). Prior to joining Oaktree in 2007, Mr. Lee worked at UBS Investment Bank in Los Angeles and Lehman Brothers in New York. He received a B.A. degree in economics from Swarthmore College and his master's degree from Harvard University. Mr. Lee serves as a director of Neo Performance Materials (TSX: NEO) and previously served on the boards of Nine Entertainment and Charter Communications.
As the Independent Director of Sorrento Therapeutics Inc, the total compensation of Edgar Lee at Sorrento Therapeutics Inc is $215,250. There are 9 executives at Sorrento Therapeutics Inc getting paid more, with Jaisim Shah having the highest compensation of $10,971,100.
Edgar Lee is 43, he's been the Independent Director of Sorrento Therapeutics Inc since 2019. There are 10 older and 2 younger executives at Sorrento Therapeutics Inc. The oldest executive at Sorrento Therapeutics Inc is Dr. Michael A. Royal, 67, who is the SVP & Chief Medical Officer.
Edgar's mailing address filed with the SEC is C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTORS PLACE, SAN DIEGO, CA, 92121.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee, and Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: